| 1 | AGA Clinical Practice Update on Surveillance for Hepatobiliary Cancers in Patients With Primary Sclerosing Cholangitis: Expert Review. 2019 · Clin Gastroenterol Hepatol | | +0.550 79 cites |
| 2 | Predicting Outcomes in Pediatric Ulcerative Colitis for Management Optimization: Systematic Review and Consensus Statements From the Pediatric Inflammatory Bowel Disease-Ahead Program. Orlanski-Meyer · 2021 · Gastroenterology | | +0.218 48 cites |
| 3 | Effects of Primary Sclerosing Cholangitis on Risks of Cancer and Death in People With Inflammatory Bowel Disease, Based on Sex, Race, and Age. 2020 · Gastroenterology | | +0.198 148 cites |
| 4 | Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis. 1991 · Gastroenterology | | +0.175 311 cites |
| 5 | Risk factors for recurrence of primary sclerosing cholangitis of liver allograft. 2002 · Lancet | | +0.156 163 cites |
| 6 | Effects of orthotopic liver transplantation and immunosuppression on inflammatory bowel disease in primary sclerosing cholangitis patients. 1993 · Transplant Proc | | +0.115 49 cites |
| 7 | Sclerosing cholangitis after continuous hepatic artery infusion of FUDR. 1985 · Ann Surg | | +0.103 135 cites |
| 8 | Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Chapman RW · 1980 · Gut | | +0.102 740 cites |
| 9 | Lymphoplasmacytic sclerosing pancreatitis with cholangitis: a variant of primary sclerosing cholangitis extensively involving pancreas. 1991 · Hum Pathol | | +0.089 466 cites |
| 10 | Vedolizumab in Inflammatory Bowel Disease Associated with Autoimmune Liver Disease Pre- and Postliver Transplantation: A Case Series. 2016 · Inflamm Bowel Dis | | +0.057 25 cites |
| 11 | Cholangiographic evaluation of bile duct carcinoma. 1983 · AJR Am J Roentgenol | | +0.046 69 cites |
| 12 | Secondary sclerosing cholangitis: a comparison to primary sclerosing cholangitis. 2005 · Am J Gastroenterol | | +0.039 78 cites |
| 13 | Abnormal hepatic biochemistries in patients with inflammatory bowel disease. 2007 · Am J Gastroenterol | | +0.031 103 cites |
| 14 | Extraintestinal manifestations of inflammatory bowel disease. 2011 · Gastroenterol Hepatol (N Y) | | +0.027 340 cites |
| 15 | The epidemiology and the pathogenesis of inflammatory bowel disease. 2000 · Eur J Radiol | | +0.024 201 cites |
| 16 | Low-dose weekly methotrexate for unusual neutrophilic vascular reactions: cutaneous polyarteritis nodosa and Behçet's disease. 1991 · J Am Acad Dermatol | | +0.023 74 cites |
| 17 | The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. 2001 · Am J Gastroenterol | | +0.022 567 cites |
| 18 | Risk factors for biliary tract carcinogenesis. 1999 · Ann Oncol | | +0.021 169 cites |
| 19 | Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. 2004 · Gastroenterology | | +0.018 975 cites |
| 20 | Primary sclerosing cholangitis. A study of forty-two cases. 1966 · Am J Surg | | +0.016 250 cites |
| 21 | Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management. 2021 · Gastroenterology | | +0.015 659 cites |
| 22 | The association of autoimmune disorders with inflammatory bowel disease. 1989 · Q J Med | | +0.014 175 cites |
| 23 | Azithromycin may reduce cholestasis in primary sclerosing cholangitis: a case report and serendipitous observation. 2007 · Int J Immunopathol Pharmacol | | +0.012 26 cites |
| 24 | Diffuse lymphoplasmacytic acalculous cholecystitis: a distinctive form of chronic cholecystitis associated with primary sclerosing cholangitis. 1998 · Hum Pathol | | +0.012 24 cites |
| 25 | Plasma antioxidant levels in chronic cholestatic liver diseases. 2000 · Aliment Pharmacol Ther | | +0.010 53 cites |
| 26 | Oral vancomycin: treatment of primary sclerosing cholangitis in children with inflammatory bowel disease. 1998 · J Pediatr Gastroenterol Nutr | | +0.009 52 cites |
| 27 | SCLEROSING CHOLANGITIS. ASSOCIATION WITH REGIONAL ENTERITIS. 1964 · JAMA | | +0.009 57 cites |
| 28 | Gut-liver immunity. 2016 · J Hepatol | | +0.009 72 cites |
| 29 | Ulcerative colitis disease activity as subjectively assessed by patient-completed questionnaires following orthotopic liver transplantation for sclerosing cholangitis. 1991 · Dig Dis Sci | | +0.009 59 cites |
| 30 | Validity of administrative data for the diagnosis of primary sclerosing cholangitis: a population-based study. 2011 · Liver Int | | +0.008 25 cites |
| 31 | Primary sclerosing cholangitis in childhood. 1987 · Gastroenterology | | +0.008 130 cites |
| 32 | Immunological similarities between primary sclerosing cholangitis and chronic sclerosing sialadenitis: report of the overlapping of these two autoimmune diseases. 2000 · Dig Dis Sci | | +0.008 27 cites |
| 33 | Colorectal cancer in inflammatory bowel disease: the risk, pathogenesis, prevention and diagnosis. 2014 · World J Gastroenterol | | +0.007 309 cites |
| 34 | Primary sclerosing cholangitis associated with systemic sclerosis. 1991 · Postgrad Med J | | +0.007 26 cites |
| 35 | Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies Triantafillidis · 2009 · Anticancer Res | | +0.007 318 cites |
| 36 | Association of UCP2 -866 G/A polymorphism with chronic inflammatory diseases. 2009 · Genes Immun | | +0.006 78 cites |
| 37 | Development of colon cancer after liver transplantation for primary sclerosing cholangitis associated with ulcerative colitis. Higashi · 1990 · Hepatology | | +0.006 114 cites |
| 38 | Pancreatic cancer: epidemiology and risk factors. 2010 · Dig Dis | | +0.005 95 cites |
| 39 | Frequency of extraintestinal manifestations in patients with inflammatory bowel disease in Northwest Greece and review of the literature. 2002 · Dig Liver Dis | | +0.005 51 cites |
| 40 | Improving outpatient services: the Southampton IBD virtual clinic. 2012 · Postgrad Med J | | +0.005 29 cites |
| 41 | A case series of transplant recipients who despite immunosuppression developed inflammatory bowel disease. Riley · 1997 · Am J Gastroenterol | | +0.005 100 cites |
| 42 | Extraintestinal manifestations of inflammatory bowel disease. 2001 · Curr Gastroenterol Rep | | +0.005 29 cites |
| 43 | Immunohistochemical analysis of inflammation in primary sclerosing cholangitis. 1999 · Eur J Gastroenterol Hepatol | | +0.005 53 cites |
| 44 | Diagnosis and classification of ulcerative colitis. 2014 · Autoimmun Rev | | +0.005 259 cites |
| 45 | Ulcerative colitis: analyses of 116 cases (do extraintestinal manifestations effect the time to catch remission?). Ozdil · 2004 · Hepatogastroenterology | | +0.004 28 cites |
| 46 | Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies. 2008 · World J Gastroenterol | | +0.004 344 cites |
| 47 | Chronic cholestatic diseases. 2000 · J Hepatol | | +0.004 133 cites |
| 48 | Inflammatory bowel disease as a risk factor for colorectal cancer. Lukas · 2010 · Dig Dis | | +0.004 77 cites |
| 49 | Colorectal Cancer in Inflammatory Bowel Disease. Stidham Ryan · 2018 · Clin Colon Rectal Surg | | +0.003 229 cites |
| 50 | Sclerosing cholangitis in cystic fibrosis. 1988 · Scand J Gastroenterol Suppl | | +0.003 39 cites |
| 51 | Is sclerosing cholangitis complicating ulcerative colitis a reversible condition? Wood · 1980 · Lancet | | +0.003 50 cites |
| 52 | ABC of colorectal cancer. Molecular basis for risk factors. 2000 · BMJ | | +0.003 73 cites |
| 53 | Liver complications in inflammatory bowel diseases. 2013 · Dig Dis | | +0.003 25 cites |
| 54 | Simultaneous occurrence of primary sclerosing cholangitis and autoimmune chronic active hepatitis in a patient with ulcerative colitis. 1992 · Dig Dis Sci | | +0.003 79 cites |
| 55 | Ulcerative colitis-associated colorectal cancer. Yashiro M · 2014 · World J Gastroenterol | | +0.003 218 cites |
| 56 | Hepatobiliary complications of ulcerative colitis. Lupinetti · 1980 · Am J Surg | | +0.003 27 cites |
| 57 | Primary sclerosing cholangitis in Japan--analysis of 192 cases. 1997 · J Gastroenterol | | +0.003 94 cites |
| 58 | Chronic inflammatory bowel disease and cancer. Pohl · 2000 · Hepatogastroenterology | | +0.003 124 cites |
| 59 | Glomerulonephritis associated with inflammatory bowel disease. Report of a patient with chronic ulcerative colitis, sclerosing cholangitis, and acute glomerulonephritis. 1990 · Gastroenterology | | +0.003 48 cites |
| 60 | Carcinogenesis in inflammatory bowel disease. 2007 · Dig Dis | | +0.003 52 cites |
| 61 | Diagnosis and management of cholangiocarcinomas: a comprehensive review. 2004 · Hepatogastroenterology | | +0.002 30 cites |
| 62 | Aetiology and natural history of primary sclerosing cholangitis--a decade of progress? 1991 · Gut | | +0.002 42 cites |
| 63 | Anti-neutrophil cytoplasmic antibodies (ANCA): their detection and significance: report from workshops. 1994 · Pathology | | +0.002 27 cites |
| 64 | Anti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases. 2003 · Clin Exp Immunol | | +0.002 84 cites |
| 65 | Ulcerative colitis. Ghosh · 2000 · BMJ | | +0.002 57 cites |
| 66 | Malignancies in inflammatory bowel disease: fact or fiction? 2002 · Scand J Gastroenterol Suppl | | +0.002 39 cites |
| 67 | Primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome associated with inflammatory bowel disease: A case report and systematic review. Ballotin VR · 2020 · World J Clin Cases | | +0.002 21 cites |
| 68 | A survey of infectious agents as risk factors for primary sclerosing cholangitis: are Chlamydia species involved? 2002 · Eur J Gastroenterol Hepatol | | +0.002 25 cites |
| 69 | Primary sclerosing cholangitis and disease distribution in inflammatory bowel disease. 2012 · Clin Gastroenterol Hepatol | | +0.002 63 cites |
| 70 | Association of primary sclerosing cholangitis with HLA-B8. 1983 · Gut | | +0.002 227 cites |
| 71 | Risk of primary sclerosing cholangitis is associated with nonsmoking behavior. 1996 · Gastroenterology | | +0.002 77 cites |
| 72 | Liver disorders in inflammatory bowel disease. 2012 · Gastroenterol Res Pract | | +0.001 48 cites |
| 73 | Long-term complications, extraintestinal manifestations, and mortality in adult Crohn's disease in population-based cohorts. 2011 · Inflamm Bowel Dis | | +0.001 180 cites |
| 74 | Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease: a meta-analysis of 16 observational studies. 2016 · Eur J Gastroenterol Hepatol | | +0.001 126 cites |
| 75 | Patient awareness of extraintestinal manifestations of inflammatory bowel disease. Huang V · 2013 · J Crohns Colitis | | +0.001 24 cites |
| 76 | The Impact of Inflammatory Bowel Disease in Canada 2018: Extra-intestinal Diseases in IBD. 2019 · J Can Assoc Gastroenterol | | +0.001 51 cites |
| 77 | Prevalence of penetrating disease and extraintestinal manifestations of Crohn's disease detected with CT enterography. 2008 · Inflamm Bowel Dis | | +0.001 104 cites |
| 78 | Primary sclerosing cholangitis: diagnostic and management challenges. 2017 · Clin Exp Gastroenterol | | +0.001 33 cites |
| 79 | Frequency and risk factors of low immunoglobulin levels in patients with inflammatory bowel disease Rai · 2015 · Gastroenterol Rep (Oxf) | | +0.001 36 cites |
| 80 | Comorbidities in adolescents with inflammatory bowel disease: findings from a population-based cohort study. 2020 · Pediatr Res | | +0.001 20 cites |
| 81 | Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk? 2012 · World J Gastroenterol | | +0.001 161 cites |
| 82 | Extraintestinal Manifestations of Inflammatory Bowel Disease. 2015 · Inflamm Bowel Dis | | +0.001 501 cites |
| 83 | Cholangitis: Diagnosis, Treatment and Prognosis. 2017 · J Clin Transl Hepatol | | +0.001 28 cites |
| 84 | Colon Cancer: Inflammation-Associated Cancer. Shawki Sherief · 2018 · Surg Oncol Clin N Am | | +0.001 70 cites |
| 85 | Gut-liver axis. 2000 · Int J Colorectal Dis | | +0.001 92 cites |
| 86 | Colorectal cancer in patients with inflammatory bowel disease: the true impact of the risk. 2015 · Dig Dis | | +0.001 58 cites |
| 87 | Immunopathogenesis of gastrointestinal and hepatobiliary diseases. 1997 · JAMA | | +0.001 24 cites |
| 88 | Gut dysbacteriosis and intestinal disease: mechanism and treatment. 2020 · J Appl Microbiol | | +0.001 87 cites |
| 89 | The epidemiology of inflammatory bowel disease. Burisch · 2015 · Scand J Gastroenterol | | +0.001 246 cites |
| 90 | Colorectal Cancer in Inflammatory Bowel Disease. 2020 · Clin Colon Rectal Surg | | +0.001 37 cites |
| 91 | Extradigestive manifestations of IBD in pediatrics. 2009 · Eur Rev Med Pharmacol Sci | | +0.001 29 cites |
| 92 | Early onset of ulcerative colitis: long-term follow-up with special reference to colorectal cancer and primary sclerosing cholangitis. 2008 · J Pediatr Gastroenterol Nutr | | +0.001 21 cites |
| 93 | Overview of molecular pathways in inflammatory bowel disease associated with colorectal cancer development. 2013 · Eur J Gastroenterol Hepatol | | +0.001 68 cites |
| 94 | Is colonoscopy alone sufficient to screen for ulcerative colitis-associated colorectal carcinoma? Bruewer Matthias · 2003 · World J Surg | | +0.001 25 cites |
| 95 | Appropriate management of special situations in Crohn's disease (upper gastro-intestinal; extra-intestinal manifestations; drug safety during pregnancy and breastfeeding): Results of a multidisciplinary international expert panel-EPACT II. 2009 · J Crohns Colitis | | +0.000 26 cites |
| 96 | A Review of Extraintestinal Manifestations and Complications of Inflammatory Bowel Disease. 2019 · Saudi J Med Med Sci | | +0.000 38 cites |
| 97 | Antineutrophil cytoplasmic antibodies in children with inflammatory bowel disease: prevalence and diagnostic value. 1997 · J Pediatr Gastroenterol Nutr | | +0.000 38 cites |
| 98 | Extraintestinal manifestations of Crohn's disease. 2005 · Digestion | | +0.000 33 cites |
| 99 | Gastrointestinal cancers in inflammatory bowel disease: An update with emphasis on imaging findings. 2016 · Crit Rev Oncol Hematol | | +0.000 41 cites |
| 100 | Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Itzkowitz SH · 2004 · Am J Physiol Gastrointest Liver Physiol | | +0.000 1,020 cites |